4
Changes in Ownership
SANGAMO THERAPEUTICS, INC Filed Acc 0001415889-25-005704
PRESIDENT, CEO AND DIRECTOR gave up 18,151 shares (to pay taxes)
- PRESIDENT, CEO AND DIRECTOR acquired 375,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Macrae Sandy · PRESIDENT, CEO AND DIRECTOR
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Shares withheld for taxes : show line 1 in the form | −7,488 | $1.00 | $7,488 | 2,088,511 | D |
| 2025-02-25 | Shares withheld for taxes : show line 2 in the form | −10,663 | $0.96 | $10,195 | 2,077,848 | D |
| 2025-02-25 | Grant or award : show line 3 in the form | +375,000 | 2,452,848 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-25 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +1,750,000 | 1,750,000 | D |
Loading xslF345X05/form4-02262025_100229.xml…